News
The “Top 10” list of best-selling gene therapies published by Genetic Engineering & Biotechnology News (GEN) in their May 2025 issue features three products based upon license agreements for technologies originating from the NIH Intramural Research Program. Featured and ranked on the GEN list are

Looking to work with the National Institutes of Health (NIH), the world’s largest biomedical research institution? The NIH Office of Technology Transfer has updated its "Business Opportunities at the NIH" guide for companies seeking new discoveries for commercialization, research & clinical

Chemotherapy is one of the most important treatments for colorectal cancer, especially those at late stages. Camptothecin (CPT) has demonstrated antitumor activity, but failed in clinical trials due to the low solubility and adverse side effects. In other words, CPT does not circulate well in the

The Technology Transfer Center (TTC) at the National Cancer Institute (NCI) is offering an exclusive Start-Up Evaluation Option License, called Start-Up 2.0, to qualified companies for term limited evaluation of certain early-stage vaccine, therapeutic, device, and diagnostic technologies stemming